title: Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?
abstract: Identification of risk factors may help us to understand the pathogenesis of osteoporotic hip fracture as well as to formulate development of better diagnostic, prevention and treatment strategies. The present study was designed to determine the impact of multiple metabolic risk factors such as markers of systemic inflammation (C-reactive protein), immune responses-acute phase reactants (ferritin), insulin resistance (HOMA-IR) and bone remodeling (osteoprotegerin), for the prediction of hip fractures in postmenopausal osteoporotic women. The study group consisted of 115 postmenopausal women divided into two groups: Group 1 consisted of 49 women hospitalized in the Orthopedic Department, Wolfson Medical Center for the diagnosis of non-traumatic hip fracture and Group 2 contained 66 postmenopausal osteoporotic women without a history of hip fracture. Metabolic parameters were determined. Circulating OPG was significantly higher in Group 1 than in Group 2 (205.2 ± 177.1 vs 60.0 =/-22.3, p < 0.0001). While levels of hemoglobin (Hbg) as well as MCV and MCH did not differ between groups, circulating ferritin was significantly increased in Group 1 compared to the control Group 2 (217.9 ± 195.1 vs 49.7 ± 31.3, p < 0.0001). In multiple linear regression analysis, which explains about 40 % of the variability in CRP, 42 % in OPG, and 28 % in ferritin, significant by-group differences in terms of these parameters persisted even after adjustment. Elevated serum ferritin concentrations and bone remodeling marker, osteoprotegerin, are independent predictors of hip fracture in postmenopausal women hospitalized for fragility fracture.
authors: Department of Internal Medicine, Wolfson Medical Center, Holon, Israel.
authors: Y
authors: Y
authors: Lipovetzki
authors: Department of Internal Medicine, Wolfson Medical Center, Holon, Israel.|Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors: G
authors: G
authors: Zandman-Goddard
authors: Department of Ortopedics, Wolfson Medical Center, Holon, Israel.|Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors: Z
authors: Z
authors: Feldbrin
authors: Department of Endocrinology, Wolfson Medical Center, Holon, Israel. marinas@wolfson.health.gov.il.|Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. marinas@wolfson.health.gov.il.
authors: M
authors: M
authors: Shargorodsky
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000097:blood*; D006620:Hip Fractures / Q000097:blood* / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D007333:Insulin Resistance; D008403:Mass Screening; D008875:Middle Aged; D053244:Osteoprotegerin / Q000097:blood*; D017698:Postmenopause / Q000097:blood*; D014807:Vitamin D / Q000097:blood
chemical_list: D015415:Biomarkers; D053244:Osteoprotegerin; C506030:TNFRSF11B protein, human; D014807:Vitamin D; D002097:C-Reactive Protein; D005293:Ferritins
keywords: Ferritin; Hip fracture; Osteoprotegerin; Postmenopausal women